You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BBIO Exercise Disclosure
Ellis Andrea · SEC Form 4 · Filed Jul 13, 2026
Exercise
Calculated transaction value
$0
Ellis Andrea Director
BBIO
BridgeBio Pharma
BBIO
Transaction date
Jul 9, 2026
Public filing date
Jul 13, 2026
Filing lag
Filed 4 days later
BBIO daily price context
Close on/before transaction
$90.17
Jul 9, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 17,167 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001470831-26-000709
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$1.73M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bridgebio Pharma, Inc. BBIO | Exercise | Jul 9, 2026 | $287.55K |
| Bridgebio Pharma, Inc. BBIO | Sale | Jul 9, 2026 | $1.44M |
| Bridgebio Pharma, Inc. BBIO Current | Exercise | Jul 9, 2026 | $0 |